Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial
Published Online: 2014-10-16
Journal: Intensive Care Medicine•Publisher: Springer Science and Business Media LLC
Authors: Andrea Noto•Caterina Fanizza•Gianni Tognoni•Giovanni Stefano Pasetti•Luciano Gattinoni•Marilena Romero•Pietro Caironi•Ralf Thomae•Roberto Bernasconi•Roberto Latini•Roberto Oggioni•Serge Masson
